SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000200
Filing Date
2020-12-08
Accepted
2020-12-08 16:07:31
Documents
16
Period of Report
2020-12-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20201204.htm   iXBRL 8-K 38191
2 PRESS RELEASE a202012088-kex991.htm EX-99.1 10319
8 LOGO image1a.jpg GRAPHIC 6636
  Complete submission text file 0000882104-20-000200.txt   202553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20201204.xsd EX-101.SCH 2405
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20201204_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20201204_def.xml EX-101.DEF 1631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20201204_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20201204_pre.xml EX-101.PRE 12634
9 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20201204_htm.xml XML 10480
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 201375387
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences